Between January 2011 and December 2012 , 285 patients presenting with distal ureteric stones of size 5-10 mm were on consent randomly assigned to 1 of 3 outpatient treatment arms : tamsulosin ( group A ) , silodosin ( group B ) , and tadalafil ( group C ) .